成都圣诺生物制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
23
NMPA:23
Drug Approvals
Enfuvirtide for Injection
- Product Name
- 注射用恩夫韦肽
- Approval Number
- 国药准字H20143159
- Approval Date
- Aug 7, 2023
NMPA
Thymopentin for Injection
- Product Name
- 注射用胸腺五肽
- Approval Number
- 国药准字H20093226
- Approval Date
- Aug 7, 2023
NMPA
Icatibant Acetate Injection
- Product Name
- 醋酸艾替班特注射液
- Approval Number
- 国药准字H20233456
- Approval Date
- Apr 17, 2023
NMPA
Thymalfasin for Injection
- Product Name
- 注射用胸腺法新
- Approval Number
- 国药准字H20143112
- Approval Date
- Apr 6, 2023
NMPA
Somatostatin for Injection
- Product Name
- 注射用生长抑素
- Approval Number
- 国药准字H20183247
- Approval Date
- Mar 22, 2023
NMPA
Somatostatin for Injection
- Product Name
- 注射用生长抑素
- Approval Number
- 国药准字H20183248
- Approval Date
- Mar 22, 2023
NMPA
Somatostatin for Injection
- Product Name
- 注射用生长抑素
- Approval Number
- 国药准字H20183249
- Approval Date
- Mar 22, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found